Ubiquitous Pharmacogenomics (U-PGx)
  • Home
  • U-PGx
    • U-PGx Consortium
    • Work Packages
    • Deliverables
    • U-PGx Publications
    • Ethics
    • Scientific Advisory Board
  • PREPARE
    • Study Overview
    • Pharmacogenomics guidelines (DPWG)
    • FAQ
    • Downloads & Web Resources
    • LIM Survey
    • Data Collection
    • Ethics
  • Education
    • Education material
    • Events Calendar
    • Upcoming U-PGx Events
    • Past U-PGx Events
    • Links
    • Other PGx Organizations
      • PGRN
  • News
  • Login Members
  • Contact

Mary Relling joins U-PGx advisory board

Posted on May 17, 2016May 17, 2016 by WEB ADMIN

Mary Relling is a scientist at St. Jude Children’s Research Hospital where she is a member of the St. Jude Faculty, chair of the Pharmaceutical Sciences Department and she leads the CPIC initiative.

This entry was posted in News. Bookmark the permalink.

Post navigation

← Group photo from kick-off meeting
U-PGx collaborates with Teri Klein, co-principal investigator of PharmGKB and CPIC →

Recent Posts

  • 7th U-PGx Personalized Medicine Day
  • Dr. Cristina Lucía Dávila Fajardo obtains PhD degree in pharmacogenetics
  • Cathelijne van der Wouden obtains PhD degree in pharmacogenetics
  • 2,500 patients enrolled in the PREPARE study since cross-over!
  • The 3rd U-PGx Personalized Medicine Public Day was successfully organized in Patras, Greece
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668353.